Baraclude,
entecavir,
Entecavir,
142217-69-4,
Baraclude,
BMS 200475,
UNII-NNU2O4609D,
entecavir (anhydrous),
209216-23-9,
BMS-200475,
NNU2O4609D,
2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,
CHEBI:473990,
SQ 34676,
MFCD00907887,
SQ-34676,
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-1H-purin-6-one,
BMS-200475-01,
HSDB 7334,
anhydrous entecavir,
6H-Purin-6-one, 2-amino-1,9-dihydro-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-,
6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-,
Entecavirum,
Entecavir anhydrous,
Entecavir (INN),
NCGC00164563-01,
AC1L4BEC,
CHEMBL713,
DSSTox_CID_26446,
DSSTox_RID_81621,
DSSTox_GSID_46446,
SCHEMBL28648,
DTXSID4046446,
Entecavir, >=98% (HPLC),
SCHEMBL15198001,
QDGZDCVAUDNJFG-FXQIFTODSA-N,
KS-00000G4U,
ZINC3802690,
Tox21_112192,
ABP001043,
BMS200475,
AKOS015854916,
AKOS015920226,
AKOS025312554,
AC-1593,
AN-1116,
CS-3160,
DB00442,
GS-6386,
LS41110,
PB30663,
RL01752,
SQ34676,
2-amino-9-[4-hydroxy-3-(hydroxymethyl)-2-methylidene-cyclopentyl]-3H-purin-6-one,
NCGC00164563-09,
1333204-94-6,
AJ-45654,
BC677668,
BR-77289,
HY-13623,
SC-20106,
AB0071164,
AB1004838,
SQ 34,676,
AM20080880,
CAS-142217-69-4,
E0899,
FT-0083013,
D07896,
J90027,
S-7388,
217E694,
methylidenecyclopentyl]-6,9-dihydro-1H-purin-6-one,
BRD-K08206212-001-01-2,
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-,
9-[(1S,3R,4S)-4-Hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]guanine,
2-amino-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one,
2-amino-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-3,9-dihydro-6H-purin-6-one,
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylene-cyclopentyl]-1H-purin-6-one,
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylene-cyclopentyl]-3H-purin-6-one,
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one,
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one hydrate (1:1),
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one,
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one,
2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-hydroxymethyl-2-methylene-cyclopentyl]-3,9-dihydro-purin-6-one,
6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl],
Entecavir hydrate,
Entecavir;,
entecavir monohydrate,
Entecavir [USAN:INN],
C12H15N5O3,
Entecavir, 98% - 25mg 25mg,
CID153941,
C12-H15-N5-O3,
ACN-040790,
CS-T-21655,
C107734,
C413685,
ETV,
188399-46-4,
2-AMINO-9-((1S,3R,4S)-4-HYDROXY-3-(HYDROXYMETHYL)-2-METHYLENECYCLOPENTYL)-1H-PURIN-6(9H)-ONE,